HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xibornol: multiple dose pharmacokinetics and diffusion in lung, tonsillar tissue and laryngeal mucosa.

Abstract
In ten patients with severe chronic bronchitis and in a further 23 with planned resection of lung, tonsils or larynx, 500 mg doses, single or multiple, of xibornol (6-isobronyl-3, 4-xylenol) were administered for an antibacterial effect. The pharmacokinetics and diffusion of the drug in the tissues were studied. A high diffusion and distribution value of xibornol was observed, with levels in the tissues constantly higher than that in the serum. The concentrations reached within the respiratory tract were adequate for their antibacterial effect.
AuthorsF Scaglione, R Trazzi, A Odero, G Sambataro, G Savio, F Ferrara, F Fraschini
JournalInternational journal of clinical pharmacology research (Int J Clin Pharmacol Res) Vol. 8 Issue 6 Pg. 457-61 ( 1988) ISSN: 0251-1649 [Print] Switzerland
PMID3253223 (Publication Type: Journal Article)
Chemical References
  • Anti-Infective Agents
  • Camphanes
  • xibornol
Topics
  • Administration, Oral
  • Anti-Infective Agents (administration & dosage, pharmacokinetics, therapeutic use)
  • Bronchitis (drug therapy)
  • Camphanes (administration & dosage, pharmacokinetics, therapeutic use)
  • Diffusion
  • Dose-Response Relationship, Drug
  • Humans
  • Laryngeal Mucosa (metabolism)
  • Larynx (metabolism)
  • Lung (metabolism)
  • Middle Aged
  • Palatine Tonsil (metabolism)
  • Sputum (analysis)
  • Tissue Distribution

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: